Notice2024-28329
Government-Owned Inventions; Availability for Licensing
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 3, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 232 (Tuesday, December 3, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 232 (Tuesday, December 3, 2024)]
[Notices]
[Pages 95800-95801]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-28329]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions; Availability for Licensing
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The invention listed below is owned by an agency of the U.S.
Government and is available for licensing to achieve expeditious
commercialization of results of federally-funded research for the
benefit of the public health.
FOR FURTHER INFORMATION CONTACT: Licensing information may be obtained
by emailing the licensing contact Malabika Ghosh, J.D., Ph.D.; 301-827-
5414; <a href="/cdn-cgi/l/email-protection#38755954595a515359167f50574b5078565150165f574e"><span class="__cf_email__" data-cfemail="064b676a67646f6d6728416e69756e46686f6e28616970">[email protected]</span></a>, at the National Heart, Lung, and Blood,
Office of Technology Transfer and Development, 31 Center Drive Room
4A25, MSC2479, Bethesda, MD 20892-2479. A signed Confidential
Disclosure Agreement may be required to receive any unpublished
information.
SUPPLEMENTARY INFORMATION: Technology description follows.
Analogues of N-Lactoyl-Phenylalanine, Methods of Synthesis, and Methods
of Use
Available for licensing and commercial development are patent
rights covering N-Lactoyl-Phenylalanine (Lac-Phe) analogues having
appetite suppressant activity, which may be useful as therapeutics in
the treatment of obesity and related secondary diseases. The patent
rights also cover methods of synthesis of the N-Lactoyl-Phenylalanine
(Lac-Phe) analogues are also disclosed, as well as methods of use and
treatment of obesity and related secondary diseases with the Lac-Phe
analogues.
This technology is available for licensing for commercial
development in accordance with 35 U.S.C. 209 and 37 CFR part 404, as
well as for further development and evaluation under a research
collaboration.
Inventors
<bullet> Alan T. Remaley, M.D., Ph.D. NHLBI
<bullet> Anna Wolska, Ph.D. NHLBI
<bullet> Amaury Lucien-Philip Dasseux
Potential Commercial Applications
<bullet> Therapeutics
[cir] obesity
[cir] obesity co-morbidities
Development Stage
<bullet> Preclinical (data from compound optimization and in vivo
validation)
Intellectual Property
<bullet> NIH Reference No. E-160-2023-0, U.S. Provisional Patent
Application 63/585,791 filed September 27, 2023, International Patent
Application PCT/US2024/048617 filed September 26, 2024, entitled ``N-
Lactoyl-Phenylalanine (Lac-Phe) compound derivatives.''
[[Page 95801]]
Dated: November 27, 2024.
Malabika J. Ghosh,
Technology Transfer and Patent Specialist, National Heart, Lung, and
Blood Institute, Office of Technology Transfer and Development.
[FR Doc. 2024-28329 Filed 12-2-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 3, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.